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http://dx.doi.org/10.1016/j.pedneo.2Objectives: The bioactive proteins in human milk may be influenced by prolonged storage pro-
cess, pasteurization, and heat treatment. This study was conducted to evaluate the effects of
these procedures.
Materials and methods: Three forms of human milk e freshly expressed, frozen at 20C for a
prolonged duration, and pasteurized milk e were collected from 14 healthy lactating mothers
and a milk bank. The concentrations of major bioactive proteins (secretory immunoglobulin A,
lactoferrin, lysozyme, and leptin) were quantified using enzyme-linked immunosorbent assay
kits. Changes in these proteins by heat treatment at 40C or 60C for 30 minutes were further
evaluated.
Results: The mean concentrations of lactoferrin and secretory immunoglobulin A were signif-
icantly reduced by 66% and 25.9%, respectively, in pasteurized milk compared with those in
freshly-expressed milk. Heat treatment at 40C or 60C did not cause significant changes in lac-
toferrin and secretory immunoglobulin A, but there was an apparent increase in lysozyme
(p Z 0.016). There were no significant differences in leptin level among these three forms
of milk prior to (p Z 0.153) or after heat treatment (p Z 0.053).
Conclusion: Various freezing/heating/pasteurization processes applied to human milk prior to
delivery to neonates could affect the concentration of immunomodulatory proteins, especially
lactoferrin, secretory immunoglobulin A, and lysozyme. Leptin was unaffected by the variouseonatology, Department of Pediatrics, Taichung Veterans General Hospital, Number 160, Section 3,
an.
m (C.-H. Chen).
an Pediatric Association. Published by Elsevier Taiwan LLC. All rights reserved.
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Treatment effects on human milk proteins 361handling processes tested. Fresh milk was found to be the best food for neonates. Further
studies are warranted to evaluate the functional activity of these proteins and their effects
on infants’ immunological status.
Copyright ª 2013, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Human milk is the best food for neonates and is recom-
mended by the American Academy of Pediatrics and the
World Health Organization.1,2 Extensive research has
documented the diverse and compelling short- and long-
term benefits of breastfeeding in comparison with cows’
milk-based formulas. It is an invaluable food source for
neonates as it contains not only numerous nutrients but also
biologically-active proteins and immune factors3 that are
not present in other forms of milk and are particularly
beneficial for very low birth-weight neonates.4 Secretory
immunoglobulin A (sIgA), lysozyme, lactoferrin, and leptin,
for instance, have anti-infective, immune, or neuroendo-
crine properties.3,5 Several studies have shown that these
bioactive proteins are influenced by numerous factors,
including gestational age,3,6 lactation stage,7,8 the
mother’s body mass index,6 and the mother’s nutrition.9
Breastfeeding is the optimal way to preserve all of these
biologically-active proteins. However, if a baby is sick or a
mother returns to work, breastfeeding is not an option.
Mothers can express milk and refrigerate it for use later
after gentle warming. Frozen stored milk can also be used
after thawing and heating at a temperature of around
40e60C. When the mother’s own milk is unavailable or in
short supply, donor milk that has undergone Holder
pasteurization at a milk bank can also be used.
Handling of expressed milk mainly comprises cooling,
freezing, heating, and pasteurization. Studies over decades
have revealed that some of the above mentioned pro-
cedures including storage,10 pasteurization,11,12 sonifica-
tion,13 and heat treatment,14 may have an effect on the
immunologic components contained therein.
Little is known about the effect of frozen storage,
pasteurization, and heat treatment of human milk on the
level of leptin it contains. Moreover, there is no recom-
mendation for “sub-pasteurization” heat treatment
(4e60C) regarding these proteins in clinical practice. Thus,
there were two main objectives in the present study: (1) to
compare the concentrations of sIgA, lysozyme, lactoferrin,
and leptin in the different storage forms of human milk;
and (2) to further analyze the changes of these proteins
after two different temperature heat treatments (40C and
60C) used in daily practice.2. Materials and Methods
This study was approved by the Institutional Review Board
of Taichung Veterans General Hospital and Taipei City
Hospital. Informed consent was obtained from all partici-
pants prior to the study. The study was conducted atTaichung Veterans General Hospital, Taichung, Taiwan,
between October 2011 and January 2012.
2.1. Acquisition of milk samples
The three forms of human milk used in this study were as
follows: freshly expressed milk (“fresh milk” group) ob-
tained from 14 healthy lactating mothers through the Di-
vision of Neonatology, Department of Pediatrics, Taichung
Veterans General Hospital; mothers’ milk stored at e20C
for at least four weeks (“frozen milk” group), which was
intended for donation to the Mothers’ Milk Bank of Taipei
City Hospital; and pasteurized milk (“pasteurized milk”
group) obtained from the Mothers’ Milk Bank of Taipei City
Hospital. Milk in the frozen and pasteurized groups was
surplus milk obtained via random sampling for donor milk
quality control and was collected from 15 mothers through
the branch for women and children of Taipei City Hospital.
The clinical data (gestational age, birth body weight, par-
ity, and lactation date) and demographic data (maternal
age, maternal body weight, and maternal body height) of
the enrolled mothers were collected and informed consent
was obtained from all milk donors.
Milk specimens were handled as follows: fresh milk
specimens were stored at 4C from the time of collection
and processed within 24 hours; frozen or pasteurized milk
specimens were thawed at 4C for 24 hours prior to pro-
cessing as described below (see Figure 1).
2.2. Heat treatment and skimmed milk preparation
We used a water bath for heat treatment. A volume of
10 mL of thawed frozen milk was bathed in plastic tubes at
40C and 60C for 30 minutes, respectively, and was
collected for further analysis. Other specimens were
analyzed at 4C. The 10 mL human milk sample was
centrifuged at 1500g for 20 minutes at 4C to separate the
fat layer, which was subsequently discarded. These de-
fatted milk specimens were centrifuged again at 10,000g
for 10 minutes at 4C, and the supernatants (whey fraction)
were isolated. All collected samples were stored in 1-mL
aliquots and frozen at 70C until further assay.
2.3. Analytical methods
Each specimen was assayed in duplicate and measurements
were carried out according to the manufacturer’s di-
rections. The reported results represent the mean of these
two measurements. The samples were diluted if necessary.
After appropriate preparation, enzyme-linked immunosor-
bent assay (ELISA) or the following enzyme immunoassay
Figure 1 Description of the study design.
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lactoferrin, and leptin of each milk sample: (1) sIgA ELISA
kit (K8870; Immundiagnostik AG, Bensheim, Germany) with
a sensitivity of 13.4 ng/mL, intra- and interassay co-
efficients of variation of 5e9% and 7.4e8.0%, respectively;
(2) lysozyme enzyme immunoassay kit (Biomedical Tech-
nologies Inc., Stoughton, MA, USA) with a sensitivity of
0.78 ng/mL, intra- and interassay coefficients of variation of
5.3% and 7%, respectively; (3) lactoferrin enzyme immuno-
assay kit (Oxis International, Burlingame, CA, USA) with a
sensitivity of 1.0 ng/mL, intra- and interassay coefficients
of variation of 5.0% and 9.6%, respectively; (4) leptin ELISA
kit (Millipore Corporation, Billerica, MA, USA) with a sensi-
tivity of 0.5 ng/mL, intra- and interassay coefficients of
variation of 2.6e4.6% and 2.6e6.2%, respectively.2.4. Statistical analysis
Data were analyzed using SPSS 20.0 (SPSS Inc., Chicago, IL,
USA), the Kruskal-Wallis test, and the Mann-Whitney U test.
Significant differences were defined as p < 0.05.Table 1 Demographic characteristics of milk donors.
Fresh milk (n Z 14)
Age, y 31.43  2.85
Body weight, kg 55.75  9.06
Body height, m 1.60  0.06
Body mass index 21.72  3.09
Gestational age, wk 39.06  1.26
Parity 1.64  0.63
Day of lactation 148.86  78.12
Birth body weight, g 3157.60  408.23
Data are presented as mean  SD.3. Results3.1. Demographic characteristics of milk donors
A total of 47 milk specimens were used in the study: 16
fresh milk, 16 frozen milk, and 15 pasteurized milk sam-
ples. Frozen and pasteurized specimens were provided by
the Mothers’ Milk Bank of Taipei City Hospital from 15
donors, and the fresh milk samples were collected from 14
other lactating mothers. For pasteurized milk, each spec-
imen had been subjected to Holder pasteurization (62.5C
for 30 minutes, conducted by the Mothers’ Milk Bank) and
refreezing at e20C until further analysis. Among these
mothers, one of the 14 fresh milk donors had a late pre-
term twin delivery, and three of the 15 frozen/pasteurized
milk donors comprised two mothers with a late preterm
delivery and one with early preterm delivery (data not
shown). Perinatal screening examination data were not
available. The postnatal ages of these infants on the day of
lactation ranged from 2 weeks to 8 months. The de-
mographic characteristics of the donors are compared inFrozen/pasteurized milk (n Z 15) p
32.67  4.08 0.533
56.67  9.12 0.983
1.61  0.05 0.591
21.87  3.41 0.813
37.74  4.27 0.591
1.60  0.91 0.591
128.67  70.07 0.505
3074.40  797.21 0.533
Treatment effects on human milk proteins 363Table 1. There were no significant differences between the
two groups of mothers in age, body weight, body height,
body mass index, parity, day of lactation or birth body
weight of infants.3.2. Concentrations of bioactive proteins in
different forms of milk
A comparison of the bioactive protein analyzed in the three
different forms of human milk is shown in Figure 2. The
mean concentrations of lactoferrin in pasteurized milk and
frozen milk were 66% and 11.5% lower, respectively,
compared with that in fresh milk (p < 0.0001 and
pZ 0.445). Compared with fresh milk, the concentration of
lysozyme in frozen milk was 39.8% lower (p < 0.0001). The
concentration of lysozyme was slightly lower in pasteurized
milk, but much lower in frozen milk in comparison with that
in fresh milk (pZ 0.078 and p < 0.0001, respectively). The
mean concentrations of sIgA were 8.2% and 25.9% lower in
frozen milk and pasteurized milk, respectively (p Z 0.171
and p Z 0.0004), compared with that in fresh milk. In
comparison with fresh milk, sIgA in frozen milk was lower
but not significantly so (p Z 0.171). No differences in
concentrations of leptin were found among the three forms
of human milk (p Z 0.153).Figure 2 Concentrations of bioactive proteins in different form
secretory immunoglobulin A (sIgA), and leptin, in whey fractions
prolonged frozen human milk (frozen, nZ 16) or pasteurized huma
Materials and methods section. *p < 0.0001 for fresh or frozen vers
***p < 0.05 for fresh or frozen versus pasteurized milk.3.3. Change in bioactive proteins after heat
treatment
A comparison of the bioactive proteins after two different
temperature heat treatments is shown in Figure 3.
Compared with the 4C group, the concentration of lacto-
ferrin was not significantly affected at 40C or 60C
(p Z 0.317). Similarly, heat treatment did not cause sig-
nificant changes in the concentration of sIgA (p Z 0.589).
The mean concentrations of lysozyme increased signifi-
cantly, however, with heat treatment: by 53.2% and 56.3%
at 40C and 60C, respectively (pZ 0.032 and pZ 0.0039).
No significant differences were noted in leptin level be-
tween each of the heat treatment groups and that of the
4C group, but there was a slight difference between the
40C and 60C groups (p Z 0.021).
4. Discussion
Neonates and preterm infants are especially prone to a
variety of infectious pathogens as their immune system is
immature. Passive immunity provides sufficient protection
against infections via maternal immunoglobulin G anti-
bodies transported transplacentally during the last
trimester of pregnancy and via sIgA antibodies in breasts of human milk. The concentrations of lactoferrin, lysozyme,
isolated from freshly expressed human milk (fresh, n Z 16),
n milk (pasteurized, nZ 15) were analyzed as described in the
us pasteurized milk; **p < 0.0001 for fresh versus frozen milk;
Figure 3 Change in bioactive proteins after heat treatment. The concentrations of lactoferrin, lysozyme, secretory immuno-
globulin A (sIgA), and leptin in whey fraction isolated from prolonged frozen human milk at 4C, 40C or 60C were assessed as
described in the Materials and methods section. *p < 0.05 for 4C versus 40C or 60C; **p < 0.05 for 40C versus 60C.
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teins in human milk (such as lactoferrin, lysozyme, and
leptin) that serve as immunomodulatory factors. These
precious factors are produced by abundant cells in human
milk.17 Studies have revealed a number of their functions:
(1) sIgA has specific antigen-targeted anti-infective action;
(2) lactoferrin plays important roles in immunomodulation,
iron chelation and antimicrobial action, and exhibits the
anti-adhesive and trophic properties necessary for intesti-
nal growth; (3) lysozyme is required for bacterial lysis and
immunomodulation18,19; and (4) leptin regulates the
neuroendocrine system and hemopoetic cells,3 and corre-
lates with neonatal weight gain20 as well as subsequent
development of obesity.21
These proteins are dynamic and most of them change
with lactation stage, but they remain at a relatively con-
stant level in mature milk.22,23
When freshly-expressed milk is unavailable, frozen
stored milk or pasteurized donor milk can be used after
appropriate handling. However, routine handling
methods in daily practice can induce changes in the
valuable nutrients contained in human milk. In the pre-
sent study, concentrations of lactoferrin, lysozyme, and
sIgA were reduced by varying amounts in the frozen and
pasteurized human milk, but not by heat treatment at
40C or 60C. By contrast, lysozyme was found to be
present in greater concentrations in sub-pasteurization
heat-treated milk. The concentration of leptin, however,
remained relatively unchanged in all forms of humanmilk tested as well in the different heat treatment
groups.
Expressed human milk is often refrigerated for days and
frozen for months if not used immediately. Earlier studies
by Bjorksten et al and Evans et al reported a minimal effect
on human milk by freezing24 and found no significant
changes in lactoferrin, lysozyme, or IgA after freezing for
3 months.25 A recent study by Akinbi and associates sug-
gested that frozen storage resulted in a lower reduction in
sIgA, lactoferrin, and lysozyme in comparison with
pasteurization.12 Similarly, our study revealed a non-
significant decrease in most of these proteins, except for
lysozyme, in frozen milk. With respect to the retention of
bioactive proteins, our data support the use of frozen milk
as an alternative to fresh milk in daily practice.
Holder pasteurization (62.5C for 30 minutes) arose from
the need to eliminate pathogen transmission via raw donor
milk and is now required by the Human Milk Banking Asso-
ciation of North America and many other national milk
banking guidelines.26 However, pasteurized milk from milk
banks undergoes complex handling after collection,
including two cycles of freezing and thawing interspaced by
heating using the Holder method prior to delivery to neo-
nates. Several studies have shown significant attenuation of
macro- and micronutrients after pasteurization.12,26,27 The
findings of the present study support previously reported
results showing a substantial decrease in sIgA and lacto-
ferrin in pasteurized milk. The minimal effect on lysozyme
by the Holder method in this study is compatible with
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leptin seemed more stable to pasteurization in comparison
with other bioactive proteins. This finding is somewhat
different from the report by Resto et al, who suggested that
leptin diminished after pasteurization.29 This difference
may be due to the different pasteurization methods used in
our study and theirs. Although the correlation between
diminutions of these proteins and clinical outcome is
not yet well clarified, faster and significantly increased
bacterial proliferation in pasteurized donor milk was
observed.12,24 Later contamination of pasteurized milk
during shipment should be carefully avoided due to the
compromised innate bacteriostatic properties. For better
preservation of these proteins, different types of pasteur-
ization method were developed,11,30,31 but the Holder
method has remained the standard and is the most widely
accepted.
Generally proteins denature more rapidly with increased
temperature. In the 1970s several experts reported on
human milk content that was subjected to heat treatments
of graded severity.14,25,28 In Figure 3 we present the
changes in these protein levels after subpasteurization heat
treatments at 40C or 60C. Little effect on lactoferrin,
sIgA, and leptin was noted, whereas lysozyme concentra-
tion was significantly increased by heat treatment, which is
consistent with previous reports that suggested this
component was not only thermally stable but also largely
sequestered in human milk.25,30,32 Sensitivity of lactoferrin,
sIgA and lysozyme to heat treatments of graded severity has
been illustrated in different reports,11,14,25,28,30,32 and we
may find a small consistency as heat treatments below
62.5C (the heat treatment temperature in the Holder
method) have a minimal impact on lactoferrin, sIgA, and
lysozyme, whereas heat treatments above 62.5C make
inactivate these proteins more rapidly. When heating up to
70e73C, few proteins survive.24 However, many heat
treatment-associated factors, such as heating time, heat
treatment design, milk volume processed, total milk pro-
teins, and analytical method, may also influence the result
and should be taken into consideration when being applied
to daily practice.
Freshly-expressed human milk remains the optimal food
for infants. Our data again support this opinion and indicate
that the handling process can have a large or small influ-
ence on the nutrient contents of human milk. Lactoferrin,
sIgA, and lysozyme, the most frequently studied immu-
noactive proteins in human milk, are susceptible to com-
plex handling but are mostly preserved under freezing or
heat treatments below 60C. Leptin has the greatest sta-
bility to freezing, heating, or pasteurization. It is novel and
of interest because preterm or low-birth-weight infants are
often fed with frozen or pasteurized milk, which has as
much leptin as fresh milk. Further studies about the effects
on neonatal weight gain and neuroendocrine system
maturation by leptin in processed milk are warranted.
There are still some limitations in this study: we quantified
these proteins but their qualities and activities were not
measured. Correlations between diminished immunomod-
ulatory proteins in human milk and neonatal immunological
outcome are also needed for clarification.
In conclusion, biologically-active proteins in human milk
are susceptible to variable handling, such as heating andpasteurization. A mother’s own freshly expressed milk re-
mains the best food for neonates as it contains the most
unaffected, valuable nutrients. Frozen milk may be sug-
gested as an alternative choice if fresh milk is unavailable
and low-grade heat treatments (below 60C) are
permissible.Acknowledgments
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